These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


341 related items for PubMed ID: 9777351

  • 21. Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas.
    Lee JH, Kavanagh JJ, Wildrick DM, Wharton JT, Blick M.
    Cancer Res; 1990 May 01; 50(9):2724-8. PubMed ID: 2328498
    [Abstract] [Full Text] [Related]

  • 22. [Complex characteristics of the alterations of oncogenes HER-2/ERBB-2, HER-1/ERBB-1, HRAS-1, C-MYC and antioncogenes p53, RB1, as well as deletions of loci of chromosome 17 in colon carcinoma].
    Kniazev PG, Imianitov EN, Chernitsa OI, Nikiforova IF, Babenko VI, Bruderliaĭn S, Plutalo OV, Kuz'min AI, Kaboev OK, Berlin IuA.
    Mol Biol (Mosk); 1992 May 01; 26(5):1134-47. PubMed ID: 1470178
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Allele loss patterns on chromosome 17q in 109 breast carcinomas indicate at least two distinct target regions.
    Cornelis RS, Devilee P, van Vliet M, Kuipers-Dijkshoorn N, Kersenmaeker A, Bardoel A, Khan PM, Cornelisse CJ.
    Oncogene; 1993 Mar 01; 8(3):781-5. PubMed ID: 8437862
    [Abstract] [Full Text] [Related]

  • 25. Frequent allelic losses and mutations of the p53 gene in human ovarian cancer.
    Okamoto A, Sameshima Y, Yokoyama S, Terashima Y, Sugimura T, Terada M, Yokota J.
    Cancer Res; 1991 Oct 01; 51(19):5171-6. PubMed ID: 1680546
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Accumulation of genetic alterations and progression of primary breast cancer.
    Sato T, Akiyama F, Sakamoto G, Kasumi F, Nakamura Y.
    Cancer Res; 1991 Nov 01; 51(21):5794-9. PubMed ID: 1682035
    [Abstract] [Full Text] [Related]

  • 28. Genetic alteration mapping on chromosome 7 in primary breast cancer.
    Bièche I, Khodja A, Driouch K, Lidereau R.
    Clin Cancer Res; 1997 Jun 01; 3(6):1009-16. PubMed ID: 9815778
    [Abstract] [Full Text] [Related]

  • 29. Loss and gain of distinct regions of chromosome 1q in primary breast cancer.
    Bièche I, Champème MH, Lidereau R.
    Clin Cancer Res; 1995 Jan 01; 1(1):123-7. PubMed ID: 9815894
    [Abstract] [Full Text] [Related]

  • 30. Two distinct regions involved in 1p deletion in human primary breast cancer.
    Bièche I, Champème MH, Matifas F, Cropp CS, Callahan R, Lidereau R.
    Cancer Res; 1993 May 01; 53(9):1990-4. PubMed ID: 8097672
    [Abstract] [Full Text] [Related]

  • 31. A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus.
    Jacobs IJ, Smith SA, Wiseman RW, Futreal PA, Harrington T, Osborne RJ, Leech V, Molyneux A, Berchuck A, Ponder BA.
    Cancer Res; 1993 Mar 15; 53(6):1218-21. PubMed ID: 8095178
    [Abstract] [Full Text] [Related]

  • 32. Analysis of allelic imbalance on chromosome 17p13 in stage I and stage II epithelial ovarian cancers.
    Wiper DW, Zanotti KM, Kennedy AW, Belinson JL, Casey G.
    Gynecol Oncol; 1998 Oct 15; 71(1):77-82. PubMed ID: 9784323
    [Abstract] [Full Text] [Related]

  • 33. Frequent loss of heterozygosity in the region including BRCA1 on chromosome 17q in squamous cell carcinomas of the esophagus.
    Mori T, Aoki T, Matsubara T, Iida F, Du X, Nishihira T, Mori S, Nakamura Y.
    Cancer Res; 1994 Apr 01; 54(7):1638-40. PubMed ID: 7907942
    [Abstract] [Full Text] [Related]

  • 34. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.
    Sato T, Tanigami A, Yamakawa K, Akiyama F, Kasumi F, Sakamoto G, Nakamura Y.
    Cancer Res; 1990 Nov 15; 50(22):7184-9. PubMed ID: 1977515
    [Abstract] [Full Text] [Related]

  • 35. Cytogenetic alterations in eight mammary tumors and tumor-suppressor gene p53 mutation in one mammary tumor from dogs.
    Mayr B, Dressler A, Reifinger M, Feil C.
    Am J Vet Res; 1998 Jan 15; 59(1):69-78. PubMed ID: 9442248
    [Abstract] [Full Text] [Related]

  • 36. P53 mutations and loss of heterozygosity on chromosomes 8p, 16q, 17p, and 18q are confined to advanced prostate cancer.
    Massenkeil G, Oberhuber H, Hailemariam S, Sulser T, Diener PA, Bannwart F, Schäfer R, Schwarte-Waldhoff I.
    Anticancer Res; 1994 Jan 15; 14(6B):2785-90. PubMed ID: 7872719
    [Abstract] [Full Text] [Related]

  • 37. Prospective assessment of allelic losses at 4p14-16 in colorectal cancer: two mutational patterns and a locus associated with poorer survival.
    Arribas R, Ribas M, Risques RA, Masramon L, Tórtola S, Marcuello E, Aiza G, Miró R, Capellà G, Peinado MA.
    Clin Cancer Res; 1999 Nov 15; 5(11):3454-9. PubMed ID: 10589758
    [Abstract] [Full Text] [Related]

  • 38. Deletion of chromosome 17p loci in breast cancer cells detected by fluorescence in situ hybridization.
    Matsumura K, Kallioniemi A, Kallioniemi O, Chen L, Smith HS, Pinkel D, Gray J, Waldman FM.
    Cancer Res; 1992 Jun 15; 52(12):3474-7. PubMed ID: 1350754
    [Abstract] [Full Text] [Related]

  • 39. [Accumulation of genetic alterations during human tumor progression].
    Yokota J, Ookawa K.
    Gan To Kagaku Ryoho; 1993 Feb 15; 20(3):321-5. PubMed ID: 8094949
    [Abstract] [Full Text] [Related]

  • 40. Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma.
    Fujiwara Y, Emi M, Ohata H, Kato Y, Nakajima T, Mori T, Nakamura Y.
    Cancer Res; 1993 Mar 01; 53(5):1172-4. PubMed ID: 8439963
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 18.